Journal
RESEARCH POLICY
Volume 36, Issue 4, Pages 477-498Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.respol.2007.02.016
Keywords
strategic alliance; biotechnology industry; brokerage; social networks; technology transfer
Categories
Ask authors/readers for more resources
Many young biotechnology firms act as intermediaries in tripartite alliance chains. They enter upstream partnerships with public sector research institutions, and later form commercialization alliances with established, downstream firms. We examine the alliance activity in a large sample of biotechnology firms and find: (i) firms with multiple in-licensing agreements are more likely to attract revenue-generating alliances with downstream partners; however, (ii) the positive relationship between in-licenses and downstream alliances attenuates as firms mature, and (iii) the diversity and the quality of the academic connections of firms' principals influences their chances of successfully acquiring commercialization fights to scientific discoveries in universities. (c) 2007 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available